Acute severe idiopathic lymphoid interstitial pneumonia - Université de Reims Champagne-Ardenne Accéder directement au contenu
Article Dans Une Revue Medicine Année : 2020

Acute severe idiopathic lymphoid interstitial pneumonia

Youssef Lamkouan
  • Fonction : Auteur
Jeanne Marie Perotin
  • Fonction : Auteur
Remi Picot
  • Fonction : Auteur
Anne Durlach
  • Fonction : Auteur
Olivier Passouant
  • Fonction : Auteur
Sebastian Sandu
  • Fonction : Auteur
Maxime Dewolf
  • Fonction : Auteur
Antoine Dumazet
  • Fonction : Auteur
François Lebargy
  • Fonction : Auteur
Gaëtan Deslee
  • Fonction : Auteur
  • PersonId : 933696
Claire Launois

Résumé

Rationale: Lymphoid interstitial pneumonia is a rare benign pulmonary lymphoproliferative disorder usually presenting with a subacute or chronic condition and frequently associated with autoimmune disorders, dysgammaglobulinemia, or infections. Patient concerns: A 74-year-old woman with no past medical history presented with acute dyspnea, nonproductive cough, hypoxemia (room air PaO 2 : 48 mmHg) and bilateral alveolar infiltrates with pleural effusion. Antibiotics and diuretics treatments did not induce any improvement. No underlying condition including cardiac insufficiency, autoimmune diseases, immunodeficiency, or infections was found after an extensive evaluation. Bronchoalveolar lavage revealed a lymphocytosis (60%) with negative microbiological findings. High-dose intravenous corticosteroids induced a mild clinical improvement only, which led to perform a surgical lung biopsy revealing a lymphoid interstitial pneumonia with no sign of lymphoma or malignancies. Diagnoses: Acute severe idiopathic lymphoid interstitial pneumonia. Interventions: Ten days after the surgical lung biopsy, the patient experienced a dramatic worsening leading to invasive mechanical ventilation. Antibiotics and a new course of high-dose intravenous corticosteroids did not induce any improvement, leading to the use of rituximab which was associated with a dramatic clinical and radiological improvement allowing weaning from mechanical ventilation after 10 days. Outcomes: Despite the initial response to rituximab, the patient exhibited poor general state and subsequent progressive worsening of respiratory symptoms leading to consider symptomatic palliative treatments. The patient died 4 months after the diagnosis of lymphoid interstitial pneumonia. Lessons: Idiopathic lymphoid interstitial pneumonia may present as an acute severe respiratory insufficiency with a potential transient response to rituximab. Abbreviations: EBV = Epstein-Barr virus, HIV = human immunodeficiency virus, HTLV-1 = human T-cell lymphotropic virus-1, LIP = lymphoid interstitial pneumonia.
Fichier principal
Vignette du fichier
Acute_severe_idiopathic_lymphoid_interstitial.111.pdf (874.92 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03425114 , version 1 (10-11-2021)

Identifiants

Citer

Youssef Lamkouan, Sandra Dury, Jeanne Marie Perotin, Remi Picot, Anne Durlach, et al.. Acute severe idiopathic lymphoid interstitial pneumonia. Medicine, 2020, 99, ⟨10.1097/md.0000000000021473⟩. ⟨hal-03425114⟩

Collections

URCA IRMAIC
58 Consultations
71 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More